#Banerji protocol symphytum 200 series#

#Banerji protocol symphytum 200 series#

The Prasanta Banerji Homeopathic Research Foundation ( ) is well known for its cancer treatment protocols, having been identified by NCI in 1999 for its Best Case Series with subsequent translational research on specific homeopathic medicines (HM) being done at MD Anderson. The Banerji Protocols help to alleviate this obstacle. These findings will soon address the plausibility question however, individualized homeopathy may remain obscure due to the need for hundreds of hours of training required for effective practice where a different remedy may be needed for every patient regardless of condition. Recent basic science research suggests that this argument will no longer hold water with the demonstration that classically prepared ultradilute homeopathic medicines (HM) contain measurable source nanoparticles (NP) and/or silica NP with adsorbed source materials that are heterogeneously dispersed in colloidal solution and have biological properties that differ substantially from bulk forms of the same substance. Specific effects of homeopathic treatment are often dismissed as unbelievable due to use of remedies diluted beyond Avogadro's number. Focus Areas: Integrative Approaches to Care